These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11160254)

  • 1. Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo.
    Steinbrecher A; Reinhold D; Quigley L; Gado A; Tresser N; Izikson L; Born I; Faust J; Neubert K; Martin R; Ansorge S; Brocke S
    J Immunol; 2001 Feb; 166(3):2041-8. PubMed ID: 11160254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
    Reinhold D; Biton A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1935-42. PubMed ID: 17161346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26.
    Preller V; Gerber A; Wrenger S; Togni M; Marguet D; Tadje J; Lendeckel U; Röcken C; Faust J; Neubert K; Schraven B; Martin R; Ansorge S; Brocke S; Reinhold D
    J Immunol; 2007 Apr; 178(7):4632-40. PubMed ID: 17372022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones.
    Reinhold D; Hemmer B; Gran B; Born I; Faust J; Neubert K; McFarland HF; Martin R; Ansorge S
    J Neuroimmunol; 1998 Jul; 87(1-2):203-9. PubMed ID: 9670864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent actions by inhibitors of DP IV and APN family enzymes on CD4+ Teff cell motility and functions.
    Biton A; Ansorge S; Bank U; Täger M; Reinhold D; Brocke S
    Immunobiology; 2011 Dec; 216(12):1295-301. PubMed ID: 21802166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoreactive T cells persist in rats protected against experimental autoimmune encephalomyelitis and can be activated through stimulation of innate immunity.
    Conant SB; Swanborg RH
    J Immunol; 2004 May; 172(9):5322-8. PubMed ID: 15100271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase IV in inflammatory CNS disease.
    Steinbrecher A; Reinhold D; Quigley L; Gado A; Tresser N; Izikson L; Born I; Faust J; Neubert K; Martin R; Ansorge S; Brocke S
    Adv Exp Med Biol; 2000; 477():145-53. PubMed ID: 10849741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) induces secretion of transforming growth factor-beta 1 (TGF-beta 1) in stimulated mouse splenocytes and thymocytes.
    Reinhold D; Bank U; Bühling F; Täger M; Born I; Faust J; Neubert K; Ansorge S
    Immunol Lett; 1997 Jun; 58(1):29-35. PubMed ID: 9436466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
    Reinhold D; Goihl A; Wrenger S; Reinhold A; Kühlmann UC; Faust J; Neubert K; Thielitz A; Brocke S; Täger M; Ansorge S; Bank U
    Clin Chem Lab Med; 2009; 47(3):268-74. PubMed ID: 19676138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl peptidase IV (CD26): role in T cell activation and autoimmune disease.
    Reinhold D; Hemmer B; Gran B; Steinbrecher A; Brocke S; Kähne T; Wrenger S; Born I; Faust J; Neubert K; Martin R; Ansorge S
    Adv Exp Med Biol; 2000; 477():155-60. PubMed ID: 10849742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells.
    Reinhold D; Bank U; Bühling F; Lendeckel U; Faust J; Neubert K; Ansorge S
    Immunology; 1997 Jul; 91(3):354-60. PubMed ID: 9301523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells.
    Hofstetter HH; Shive CL; Forsthuber TG
    J Immunol; 2002 Jul; 169(1):117-25. PubMed ID: 12077236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts.
    Thielitz A; Vetter RW; Schultze B; Wrenger S; Simeoni L; Ansorge S; Neubert K; Faust J; Lindenlaub P; Gollnick HP; Reinhold D
    J Invest Dermatol; 2008 Apr; 128(4):855-66. PubMed ID: 17943180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase IV (DP IV, CD26) is involved in regulation of DNA synthesis in human keratinocytes.
    Reinhold D; Vetter RW; Mnich K; Bühling F; Lendeckel U; Born I; Faust J; Neubert K; Gollnick H; Ansorge S
    FEBS Lett; 1998 May; 428(1-2):100-4. PubMed ID: 9645485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells.
    Reinhold D; Bank U; Bühling F; Kähne T; Kunt D; Faust J; Neubert K; Ansorge S
    Immunobiology; 1994 Dec; 192(1-2):121-36. PubMed ID: 7750986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain variation in autoimmunity: attempted tolerization of DA rats results in the induction of experimental autoimmune encephalomyelitis.
    Lenz DC; Wolf NA; Swanborg RH
    J Immunol; 1999 Aug; 163(4):1763-8. PubMed ID: 10438907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibitors of dipeptidyl peptidase IV suppress mRNA expression of DP IV/CD26 and cytokines.
    Arndt M; Reinhold D; Lendeckel U; Spiess A; Faust J; Neubert K; Ansorge S
    Adv Exp Med Biol; 2000; 477():139-43. PubMed ID: 10849740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase IV (DP IV/CD26) mRNA expression in PWM-stimulated T-cells is suppressed by specific DP IV inhibition, an effect mediated by TGF-beta(1).
    Arndt M; Lendeckel U; Spiess A; Faust J; Neubert K; Reinhold D; Ansorge S
    Biochem Biophys Res Commun; 2000 Aug; 274(2):410-4. PubMed ID: 10913352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
    Miller A; Lider O; Roberts AB; Sporn MB; Weiner HL
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):421-5. PubMed ID: 1370356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PETIR-001, a dual inhibitor of dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN), ameliorates experimental autoimmune encephalomyelitis in SJL/J mice.
    Reinhold D; Bank U; Entz D; Goihl A; Stoye D; Wrenger S; Brocke S; Thielitz A; Stefin S; Nordhoff K; Heimburg A; Täger M; Ansorge S
    Biol Chem; 2011 Mar; 392(3):233-7. PubMed ID: 21194377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.